Park K - Search Results

1

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience.

Paik S, Bryant J, Tan-Chiu E, Romond E, Hiller W, Park K, Brown A, Yothers G, Anderson S, Smith R, Wickerham DL, Wolmark N. Paik S, et al. Among authors: park k. J Natl Cancer Inst. 2002 Jun 5;94(11):852-4. doi: 10.1093/jnci/94.11.852. J Natl Cancer Inst. 2002. PMID: 12048273

2

c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers.

Park K, Kwak K, Kim J, Lim S, Han S. Park K, et al. Hum Pathol. 2005 Jun;36(6):634-9. doi: 10.1016/j.humpath.2005.04.016. Hum Pathol. 2005. PMID: 16021569

3

Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray.

Park K, Kim J, Lim S, Han S, Lee JY. Park K, et al. Mod Pathol. 2003 Sep;16(9):937-43. doi: 10.1097/01.MP.0000086487.78558.7D. Mod Pathol. 2003. PMID: 13679458

4

Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer.

Park K, Han S, Gwak GH, Kim HJ, Kim J, Kim KM. Park K, et al. Breast Cancer Res Treat. 2006 Aug;98(3):337-42. doi: 10.1007/s10549-006-9170-7. Epub 2006 Feb 24. Breast Cancer Res Treat. 2006. PMID: 16502015

5

Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer.

Park K, Han S, Kim JY, Kim HJ, Kwon JE, Gwak G. Park K, et al. J Breast Cancer. 2011 Dec;14(4):276-82. doi: 10.4048/jbc.2011.14.4.276. Epub 2011 Dec 27. J Breast Cancer. 2011. PMID: 22323913 Free PMC article.

6

E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide.

Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY. Han S, et al. Among authors: park k. Breast Cancer Res Treat. 2003 Nov;82(1):11-6. doi: 10.1023/B:BREA.0000003843.53726.63. Breast Cancer Res Treat. 2003. PMID: 14672398

7

Clinicopathological significance and diagnostic accuracy of HER2 immunohistochemistry in colorectal cancer: a meta-analysis.

Pyo JS, Kang G, Park K. Pyo JS, et al. Among authors: park k. Int J Biol Markers. 2016 Dec 23;31(4):e389-e394. doi: 10.5301/jbm.5000208. Int J Biol Markers. 2016. PMID: 27102863 Free article. Review.

8

Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.

Han S, Kim J, Sohn S, Kwak GH, Kim JY, Park K. Han S, et al. Among authors: park k. J Surg Oncol. 2007 Jan 1;95(1):45-50. doi: 10.1002/jso.20715. J Surg Oncol. 2007. PMID: 17192866

9

Nodal metastasis signatures in breast cancer.

Park K, Lee JH, Han HH, Mun SG, Kang S, Cha YJ, Koo JS, Kim MJ, Lee HS, Moon J, Cho NH. Park K, et al. Pathol Res Pract. 2017 Jun;213(6):680-687. doi: 10.1016/j.prp.2016.11.017. Epub 2016 Dec 5. Pathol Res Pract. 2017. PMID: 28476377

10

Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer.

Gwak G, Park K, Shin E, Han S, Kim JY, Kim H, Kim YD, Kim HJ, Kim KW, Bae BN, Yang KH, Cho H, Park SJ. Gwak G, et al. Among authors: park sj, park k. J Breast Cancer. 2011 Sep;14(3):223-8. doi: 10.4048/jbc.2011.14.3.223. Epub 2011 Sep 29. J Breast Cancer. 2011. PMID: 22031805 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,464 results

Search Page

Filters